Results 141 to 150 of about 2,777,068 (342)

Plasma Proteome Reflects Tissue Damage and Clinical Manifestations in Patients With Inflammatory Myopathies

open access: yesArthritis &Rheumatology, EarlyView.
Objective Tissue‐specific biomarkers that are reliable and associated with clinical manifestations of idiopathic inflammatory myopathy (IIM) are lacking. The blood circulation in individuals serves as a central conduit, allowing communication between tissues and facilitating clearance and recycling of tissue‐derived proteins.
Yue‐Bei Luo   +23 more
wiley   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

open access: yesBMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu   +5 more
wiley   +1 more source

A new paradigm for esophageal disease management: the application and future prospects of Shared Decision Making (SDM)

open access: yesWorld Journal of Surgical Oncology
Shared Decision Making (SDM), as a “patient-centered” medical decision-making model, has gradually demonstrated its application value in the diagnosis and treatment of esophageal diseases. This study is a structured narrative review (without quantitative
Yuanyuan Yin   +5 more
doaj   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

open access: yesBMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo   +9 more
wiley   +1 more source

Esophageal Melanocytosis as a Rare Disease of Esophagus

open access: yes
Esophageal melanocytosis is an extremely rare condition characterized by melanocyte proliferation in the esophageal squamous epithelium. The etiology and pathogenesis of the disease are unclear.
Tuğçe Eşkazan   +6 more
core   +1 more source

Micro‐ and nanoplastics in gastrointestinal disorders: Mapping the translational gap between exposure, biomonitoring, and pathogenic mechanisms

open access: yesBMEMat, EarlyView.
This review highlights critical “translational gaps” in understanding micro‐ and nanoplastics impacts on gastrointestinal diseases, bridging exposure, detecting, and mechanistic toxicology. Abstract Micro‐ and nanoplastics (MNPs) have become pervasive environmental contaminants with increasing evidence linking them to adverse health outcomes.
Zhenli Diao   +3 more
wiley   +1 more source

Esophageal microbiota and esophageal diseases

open access: yesWorld Chinese Journal of Digestology, 2019
Shuang Ma   +4 more
openaire   +1 more source

Probiotic spore‐based bioresponsive drug delivery for reversing inflammatory bowel disease and its associated anxiety and depression

open access: yesBMEMat, EarlyView.
A probiotic spore‐based drug delivery system (BCS‐Que@ApNPs) provides excellent targeted delivery, bioresponsive drug release, and long‐term retention (over 48 h), making it suitable for oral treatment of inflammatory bowel disease and its associated anxiety and depression.
Qingling Song   +9 more
wiley   +1 more source

Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets

open access: yesCellular and Molecular Gastroenterology and Hepatology, 2018
Rhonda F. Souza, MD
doaj   +1 more source

Endoscopic Polypectomy of Esophageal Leiomyomas; Report of Two Cases [PDF]

open access: yes, 1997
We describe esophageal leiomyomas in two young patients (aged 35 and 32 years), who complained of dysphagia and epigastralgia, which were successfully treated by endoscopic polypectomy.
Mizuta, Yohei   +7 more
core  

Home - About - Disclaimer - Privacy